Curis, Inc. ( CRIS) - Key Metrics
CRIS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | $0.15 | -$0.05 | -$0.05 |
| 2025Q3 | $0.20 | -$0.49 | -$0.36 | -$0.36 |
| 2025Q2 | $0.22 | -$0.68 | -$0.63 | -$0.63 |
| 2025Q1 | $0.28 | -$1.25 | -$0.85 | -$0.85 |
CRIS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 1.68 |
| 2025Q3 | ? | -0.84 |
| 2025Q2 | ? | -0.85 |
| 2025Q1 | ? | -0.42 |
CRIS
Price: $0.42
52 week price:
Earnings Per Share: -0.58 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 479800
Ebitda: -14.2 millionMarket Capitalization: 6.6 million